Multiple states have raised the alarm in the past month about cychlorphine, a synthetic opioid tied to several dozen recent ...

The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors ...

Named by the Evening Standard as one of the top 100 people shaping London in 2025, Professor David Nutt has authored over 500 research papers and more than 30 books. One of the world’s foremost ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating ...

Marseille, France, March 10, 2026 - Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of therapeutic molecules and ...

Solvonis Therapeutics PLC (LSE:SVNS, FRA:J4I), an emerging biopharmaceutical company focused on central nervous system disorders, has selected SVN-114 as the lead candidate from its proprietary ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

The Ministry of Health and Family Welfare has issued a notification introducing amendments to the Drugs Rules, 1945, reinforcing quality control and licensing requirements.The ...

A heady combination of influencers, deregulation, GLP-1 success stories and DIY medicine are driving the phenomenal growth in ...

Stories about celebrities taking propanolol, a beta-blocking drug, are all over the place. It's being used to ward off stage fright. Does it really work, or is it just more celebrity nonsense? Hint - ...

Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...